Search

everythinglearnresearchcommunity

for

Search:↓

PRP treatment may help improve hair density and thickness in breast cancer patients with therapy-induced hair loss.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Hair regrowth treatments had modest benefits for patients with long-term hair loss after chemotherapy.

Low dose oral minoxidil helps regrow hair in permanent chemotherapy-induced alopecia.

The document concludes that low-dose oral minoxidil successfully regrew hair in a patient with permanent hair loss after chemotherapy and stem cell transplant.

Some breast cancer treatments, like taxanes, can cause long-term hair loss.

Scalp cooling and minoxidil can help manage hair loss after chemotherapy.

Tamoxifen increases the risk of lasting hair loss after chemotherapy despite scalp cooling.

Prevent persistent hair loss after chemotherapy with scalp cooling and early minoxidil use.

PRP may increase hair density but doesn't improve quality of life in breast cancer survivors with hair loss.

Some pediatric Ewing's sarcoma patients may experience permanent hair loss after chemotherapy, and treatments might not fully restore hair.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

Permanent hair loss from chemotherapy significantly impacts patients' mental health and social life, highlighting the need for better patient education and support.

A woman regrew her hair after receiving injections of special cell-derived vesicles.

Low-dose oral minoxidil combined with topical minoxidil improves hair growth in breast cancer patients with therapy-induced hair loss.

Different types of persistent hair loss after chemotherapy respond differently to treatments.

Asian women with breast cancer experience the highest rates of long-term hair loss and related distress after chemotherapy.

Activating PPAR-γ signalling can protect hair follicle stem cells from damage caused by chemotherapy.

Chemotherapy for breast cancer often causes significant and lasting hair loss.

Improved collaboration and education between dermatologists and oncologists can enhance care for chemotherapy-related hair loss.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

Chemotherapy caused a woman's permanent hair loss and early menopause.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Low-dose oral minoxidil is generally safe for treating hair loss, with mostly mild side effects.

Caffeine can protect scalp hair follicles from damage caused by UV radiation.

Androgens may increase arrhythmias in Brugada Syndrome, while Finasteride could reduce them.

Minoxidil effectively treats hair loss, but use cautiously and monitor side effects.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.